secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001829126-25-000905
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel removes preferred stock ownership caps and increases authorized shares to 250M
--------------------------------------------------------------------------------

- Stockholders removed Series C and D convertible preferred stock ownership limitations, eliminating conversion caps.
- Authorized common shares increased from 100M to 250M; charter amendment filed Feb 10, 2025.
- David Lazar received 2.1M Series D preferred shares after Series D amendment removal of the 49.99% cap.
- Series C amendment removed 5% ownership limit; Series D removed 49.99% limit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625000905/0001829126-25-000905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625000905/cyclacel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-000905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer